| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 04/12/2006 | CN1757634A Intermidiate for preparing 1,2-oxygen nitrogen heterocyclic-2-alkene acylbenzene and its preparation |
| 04/11/2006 | US7026346 Anticancer agents |
| 04/06/2006 | WO2005068442A3 Isoxazole derivatives and their use as cyclooxygenase inhibitors |
| 04/06/2006 | US20060074246 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 04/06/2006 | US20060074110 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/06/2006 | US20060073971 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethysilylisoxazole; crop protection agents to combat or prevent fungal infestations, or to control other pests such as weeds, insects, or acarids |
| 04/05/2006 | EP1641759A2 Malonamide derivatives |
| 04/05/2006 | EP1641452A1 Heterocyclic compounds useful to treat hcv |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1249051C Muscarinic agonists |
| 04/04/2006 | US7022736 Enzyme inhibitors |
| 04/04/2006 | US7022725 Isoxazole derivatives |
| 04/04/2006 | US7022722 5-(ester-substituted benzyl or benzylidene)-thiazolidine-2,4-diones; readily metabolized by the physiological metabolic drug detoxification systems without loss of therapeutic benefit; lower side effects and toxicity in patients with elevated or compromised liver function |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 03/30/2006 | WO2006034333A2 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives |
| 03/30/2006 | WO2006016724A3 Liquid-crystalline compounds, compositions and thin films |
| 03/30/2006 | WO2005120515A3 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | US20060069284 Esters of allyl substituted by a difluoromethylene group, method for the synthesis thereof and use thereof |
| 03/30/2006 | US20060069267 Novel sulfonation method for zonisamide intermediate in zonisamide synthesis and their novel crystal forms |
| 03/30/2006 | CA2581072A1 Compounds for the treatment of dyslipidemia and other lipid disorders |
| 03/29/2006 | EP1638962A2 Substituted oxyarenes und deren verwendung zur bekämpfung von schädlingen |
| 03/29/2006 | EP1638941A1 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
| 03/29/2006 | EP1638928A1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides |
| 03/29/2006 | EP1638924A1 Pesticidally active ketone and oxime derivatives |
| 03/29/2006 | EP1303270B1 Method for treating cryptorchidism |
| 03/29/2006 | CN1247544C Anthranilic acid amides with heteroarylsulfonyl side chain and use thereof as active substance for antiarythmia |
| 03/28/2006 | US7019094 Intermediate products, methods for their preparation and use thereof |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 03/23/2006 | WO2006030211A2 Acyclic sulphonamides |
| 03/23/2006 | US20060063936 Sulfonation of zonisamide intermediates to form crystals |
| 03/23/2006 | US20060063930 Compositions and methods comprising proteinase activated receptor antagonists |
| 03/23/2006 | US20060063798 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/23/2006 | US20060063772 New compounds |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/22/2006 | EP1636220A1 Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders |
| 03/21/2006 | US7015330 Sulfonation method for zonisamide intermediate in zonisamide synthesis and their novel crystal forms |
| 03/21/2006 | US7015329 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 03/21/2006 | CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 03/16/2006 | WO2006027684A1 Therapeutic diphenyl ether ligands |
| 03/16/2006 | US20060058363 Nitric oxide releasing selective cyclooxygenase-2 inhibitors |
| 03/16/2006 | CA2580024A1 Therapeutic diphenyl ether ligands |
| 03/15/2006 | CN1747942A Heterocyclic compounds useful as nurr-1 activators |
| 03/15/2006 | CN1245381C Phenylglycine derivatives |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | US7012075 Cathepsin cysteine protease inhibitors |
| 03/09/2006 | WO2006024820A1 Isoxazoline derivatives and their use as herbicides |
| 03/09/2006 | WO2005105770A3 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives |
| 03/09/2006 | WO2005097751A3 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands |
| 03/09/2006 | US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 03/09/2006 | US20060052445 Diarylsulfones as 5-HT2A antagonists |
| 03/09/2006 | US20060052308 Transglutaminase inhibitors and methods of use thereof |
| 03/09/2006 | US20060051879 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 03/09/2006 | CA2577495A1 Isoxazoline derivatives and their use as herbicides |
| 03/08/2006 | EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 03/08/2006 | EP1631560A2 C-fms kinase inhibitors |
| 03/08/2006 | EP1631539A1 Esters of allyl substituted by a difluoromethylene group, method for the synthesis thereof and use thereof |
| 03/08/2006 | EP1631143A1 Hydrazone derivatives for combatting harmful insects and arachnids |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | CN1244532C Process for preparing intermediates |
| 03/02/2006 | WO2006023844A2 Compositions and methods comprising proteinase activated receptor antagonists |
| 03/02/2006 | WO2006021806A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
| 03/02/2006 | WO2006021805A1 Diarylsulfones as 5-ht2a antagonists |
| 03/02/2006 | WO2006021759A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 03/02/2006 | US20060046966 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 03/02/2006 | CA2577837A1 Diarylsulfones as 5-ht2a antagonists |
| 03/02/2006 | CA2576971A1 Compositions and methods comprising proteinase activated receptor antagonists |
| 03/02/2006 | CA2575200A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 03/01/2006 | EP1628967A1 Immunosuppressant compounds and compositions |
| 03/01/2006 | EP1203768B1 Isoxazoline derivatives and herbicides containing the same as the active ingredient |
| 03/01/2006 | EP1067927B1 Antioxidant stabilizer system for pharmaceutical formulations |
| 03/01/2006 | CN1741990A Arylalkylcarbamate derivatives production and use thereof in therapy |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 03/01/2006 | CN1243724C Amide derivatives which are useful as cell factor inhibitors |
| 02/28/2006 | US7005538 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; use to treat cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 02/28/2006 | US7005440 Therapeutic uses of tri-aryl acid derivatives |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/23/2006 | WO2005048953A3 Amide derivatives as kinase modulators |
| 02/23/2006 | US20060041095 Intermediate products, methods for their preparation and use thereof |
| 02/23/2006 | US20060040973 Novel guanidine mimics as factor Xa inhibitors |
| 02/23/2006 | CA2576388A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 02/23/2006 | CA2575188A1 Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer |
| 02/23/2006 | CA2575056A1 Selected fused heterocyclics and uses thereof |
| 02/22/2006 | EP1626962A1 Benzamide inhibitors of the p2x7 receptor |
| 02/22/2006 | CN1738807A Substituted aralkyl derivatives |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/21/2006 | US7001923 Taxol enhancer compounds |
| 02/16/2006 | WO2006015852A1 Organic compounds |
| 02/16/2006 | US20060035838 Drug therapy for celiac sprue |
| 02/16/2006 | CA2574914A1 Organic compounds |
| 02/15/2006 | CN1735598A Phenyl or heteroaryl amino alkane derivatives as IP receptor antagonist |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/14/2006 | CA2347298C Organic initiators and their use in the polymerization of unsaturated monomers |
| 02/14/2006 | CA2248598C Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
| 02/09/2006 | US20060030610 Method of treating inflammatory diseases |
| 02/09/2006 | US20060030599 Sulphonamide derivatives |
| 02/08/2006 | EP1623709A1 Remedy for rheumatoid arthritis |
| 02/08/2006 | EP1622890A2 Blockers of the quorum sensing system of gram-negative bacteria |